brokerbase

About tradingpattern.net

The movement of a security's price over a specific time period.

dedicated to value creation and applying the scientific method in finance

Search


www.brokerbase.ch network - market statistics - weekly update

www.brokerbase.ch High dividend yield stocks

www.brokerbase.ch network

3M Activision Blizzard Adobe Systems Affimetrix Airlines Akamai Tech Alcoa Altera Amazon.com American Express American Tower Amgen Amylin Pharma Analyst Rating AngloGold Apollo Group Apple Applied Materials AT&T Autodesk Automatic Data Processing Baidu Bank of America Baxter Bed Bath & Beyond Blackrock Boeing Broadcom C.H. Robinson CA Caterpillar Celgene Cephalon Charts Check Point Software Chevron Cintas Corporation Cisco Systems Citigroup Citrix Coca Cola Cognizant Comcast Costco Wholesale Cree Dell DENTSPLY DIRECTV Discount, Variety Stores DISH Disney Dow 30 Downgrade Dr. Reddy's Laboratories Du Pont eBay Electronic Arts EMC Corporation Expedia Express Scripts Extreme Networks Exxon Mobil FANNIE MAE Fastenal First Solar Fiserv Flextronics FLIR Ford Foster Wheeler FREDDIE MAC Freeport-McMoRan Garmin Genentech General Electric Genzyme Gilead Sciences Golden Star Resources Goldman Sachs Google Hansen Natural Hardware Healthcare Hecla Mining Henry Schein Hewlett Packard Hologic Home Depot Human Genome Science IBM Illumina Industry Infosys Initial Recommendation Intel InterActive Corp Intuit Intuitive Surgical Johnson & Johnson Joy Global JP Morgan Juniper Networks KKR KLA-Tencor Kraft Foods Lam Research Level 3 Liberty Global Liberty Media Life Technologies Linear Technology Lockheed Martin Logitech Marvell Technology MasterCard Maxim Integrated McDonalds Merck Merril Lynch Microchip Technology Microsoft Millicom Morgan Stanley Nasdaq 100 NetApp NETFLIX Network Network Appliance Newmont Mining News Corporation NII Holdings Noble NVIDIA O'Reilly Automotive Occidental Petroleum Oracle PACCAR Patterson Paychex Petrohawk PETROLEO BRASILEIRO Pfizer Procter & Gamble Qualcomm Quanta Renhe Commercial Holdings Research in Motion Riverbed Technology Ross Stores Royal Gold Ryanair S&P 500 salesforce.com SanDisk Seagate Sears Holdings Semiconductor - Integrated Circuits Services Sigma-Aldrich Software Southwest Airlines Staples Starbucks Steel & Iron Steel Dynamics Stericycle Symantec Synaptics Technology Teva Texas Instruments Ticker Travelers Uncategorized United Continental Holdings United Technologies Upgrade Urban Outfitters VeriSign Verizon Vertex Pharmaceuticals Visa Wal Mart Warner Chilcott Wells Fargo Wynn Resorts Xilinx XTO Yahoo Zoltek

www.brokerbase.ch network - archived market statistics

Blogroll

Recent Posts

Human Genome Science

Next Entries »

Human Genome Sciences outperform – New Analyst Rating from Robert W. Baird & Co. Incorporated

Tuesday, November 30th, 2010

Human Genome Sciences hold – New Analyst Rating from Citigroup Corp.

Friday, November 19th, 2010

Human Genome Sciences hold – New Analyst Rating from Citigroup Corp.

Thursday, November 18th, 2010

Human Genome Sciences overweight – New Analyst Rating from Barclays Capital

Tuesday, November 16th, 2010

Human Genome Sciences buy – New Analyst Rating from Stifel, Nicolaus & Co., Inc.

Friday, September 10th, 2010

Human Genome ( HGSI ) Initial Recommendation Buy – Analyst rating from Stifel Nicolaus

Thursday, September 9th, 2010

Human Genome (HGSI) Initial Recommendation – Buy – Analyst rating from Stifel Nicolaus

Thursday, September 9th, 2010

Human Genome Sciences buy – New Analyst Rating from Stifel, Nicolaus & Co., Inc.

Thursday, September 9th, 2010

Human Genome Sciences outperform – New Analyst Rating from Robert W. Baird & Co. Incorporated

Thursday, July 22nd, 2010

Human Genome ( HGSI ) Upgrade from Neutral to Outperform($32) – Analyst rating from Robert W. Baird

Thursday, July 22nd, 2010

Human Genome (HGSI) Initial Recommendation – Outperform – Analyst rating from RBC Capital Mkts

Wednesday, January 27th, 2010

Human Genome Sciences neues Kursziel – New Analyst Rating from UBS AG

Friday, January 15th, 2010

Human Genome Sciences Downgrade – New Analyst Rating from Goldman Sachs Group Inc.

Monday, January 11th, 2010

Human Genome Sciences dabeibleiben – New Analyst Rating from Der Aktionaer

Tuesday, January 5th, 2010

Human Genome Sciences dabeibleiben – New Analyst Rating from Der Aktionaer

Monday, January 4th, 2010

Human Genome Sciences overweight – New Analyst Rating from Morgan Stanley

Tuesday, December 22nd, 2009

Human Genome Sciences neues Kursziel – New Analyst Rating from Citigroup Corp.

Tuesday, December 1st, 2009

New Analyst Rating from JP Morgan Chase & Co. – Human Genome Sciences overweight

Friday, October 30th, 2009

Human Genome Sciences buy

Saturday, January 26th, 2008

Piper Jaffray stufen die Aktie von Human Genome Sciences von “neutral” auf “buy” hoch. Das Kursziel wird von 11 auf 9,00 USD gesenkt.

Human Genome Sciences outperform

Saturday, January 26th, 2008

Bear Stearns stufen die Aktie von Human Genome Sciences von “peer perform” auf “outperform” hoch.

Human Genome Sciences neues Kursziel

Saturday, January 26th, 2008

UBS stufen die Aktie von Human Genome Sciences unverändert mit “buy” ein. Das Kursziel wird von 17 auf 7,50 USD gesenkt.

Human Genome Sciences Downgrade

Saturday, January 26th, 2008

Die Analysten von Merrill Lnch stufen die Aktie von Human Genome Sciences von “buy” auf “neutral” zurück.

Human Genome Sciences neues Kursziel

Saturday, January 26th, 2008

JMP Securities stufen die Aktie von Human Genome Sciences unverändert mit “market outperform” ein. Das Kursziel wird von 15 auf 9,00 USD gesenkt.

Human Genome Sciences buy

Friday, January 11th, 2008

Human Genome Sciences unverändert mit “buy” ein. Das Kursziel wird bei 17 USD gesehen.

Human Genome Sciences buy

Friday, January 11th, 2008

UBS stufen die Aktie von Human Genome Sciences unverändert mit “buy” ein. Das Kursziel wird bei 17 USD gesehen.

Next Entries »